Publication Information

{'id': 'https://openalex.org/W4396591836', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs23-rf01-04', 'title': 'Abstract RF01-04: Final results from the phase 2, open-label FOENIX-MBC2 study: efficacy and safety of futibatinib in adult patients with locally advanced/metastatic HR+/HER2− breast cancer harboring high-level FGFR1 gene amplification', 'display_name': 'Abstract RF01-04: Final results from the phase 2, open-label FOENIX-MBC2 study: efficacy and safety of futibatinib in adult patients with locally advanced/metastatic HR+/HER2− breast cancer harboring high-level FGFR1 gene amplification', 'publication_year': 2024, 'publication_date': '2024-05-02', 'ids': {'openalex': 'https://openalex.org/W4396591836', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs23-rf01-04'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs23-rf01-04', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5009582590', 'display_name': 'Senthil Damodaran', 'orcid': 'https://orcid.org/0000-0002-2470-0891'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Senthil Damodaran', 'raw_affiliation_strings': ['1The University of Texas MD Anderson Cancer Center, Houston, TX, United States;'], 'affiliations': [{'raw_affiliation_string': '1The University of Texas MD Anderson Cancer Center, Houston, TX, United States;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001814176', 'display_name': 'Fabrice André', 'orcid': 'https://orcid.org/0000-0001-5795-8357'}, 'institutions': [{'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Fabrice André', 'raw_affiliation_strings': ['2Faculté de Medicine Paris-Sud XI, Gustave Roussy, France;'], 'affiliations': [{'raw_affiliation_string': '2Faculté de Medicine Paris-Sud XI, Gustave Roussy, France;', 'institution_ids': ['https://openalex.org/I2801843802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061962242', 'display_name': 'Nisha Unni', 'orcid': 'https://orcid.org/0000-0003-1549-4720'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nisha Unni', 'raw_affiliation_strings': ['3University of Texas Southwestern Medical Center, Dallas, TX, United States;'], 'affiliations': [{'raw_affiliation_string': '3University of Texas Southwestern Medical Center, Dallas, TX, United States;', 'institution_ids': ['https://openalex.org/I867280407']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024838193', 'display_name': 'Marta Ferreira', 'orcid': 'https://orcid.org/0000-0002-3680-8613'}, 'institutions': [{'id': 'https://openalex.org/I4210111164', 'display_name': 'IPO Porto', 'ror': 'https://ror.org/027ras364', 'country_code': 'PT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210111164']}], 'countries': ['PT'], 'is_corresponding': False, 'raw_author_name': 'Marta Ferreira', 'raw_affiliation_strings': ['4Instituto Português de Oncologia do Porto FG, Portugal;'], 'affiliations': [{'raw_affiliation_string': '4Instituto Português de Oncologia do Porto FG, Portugal;', 'institution_ids': ['https://openalex.org/I4210111164']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090729537', 'display_name': 'Karthik V. Giridhar', 'orcid': 'https://orcid.org/0000-0003-4640-9197'}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Karthik Giridhar', 'raw_affiliation_strings': ['5Mayo Clinic, Rochester, MN, United States;'], 'affiliations': [{'raw_affiliation_string': '5Mayo Clinic, Rochester, MN, United States;', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109178293', 'display_name': 'Brooke Daniel', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I160606119', 'display_name': 'University of Tennessee Health Science Center', 'ror': 'https://ror.org/0011qv509', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I160606119']}, {'id': 'https://openalex.org/I4210126298', 'display_name': 'Duke Medical Center', 'ror': 'https://ror.org/03njmea73', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210126298', 'https://openalex.org/I4210144876']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Brooke Daniel', 'raw_affiliation_strings': ['6Duke University Medical Center, University of Tennessee Health Science Center College of Medicine, Chattanooga, TN, United States;'], 'affiliations': [{'raw_affiliation_string': '6Duke University Medical Center, University of Tennessee Health Science Center College of Medicine, Chattanooga, TN, United States;', 'institution_ids': ['https://openalex.org/I160606119', 'https://openalex.org/I4210126298']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053376791', 'display_name': 'Marco Colleoni', 'orcid': 'https://orcid.org/0000-0002-5743-3013'}, 'institutions': [{'id': 'https://openalex.org/I6141010', 'display_name': 'European Institute of Oncology', 'ror': 'https://ror.org/02vr0ne26', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153126', 'https://openalex.org/I6141010']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Marco Colleoni', 'raw_affiliation_strings': ['7Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Lombardia, Italy;'], 'affiliations': [{'raw_affiliation_string': '7Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Lombardia, Italy;', 'institution_ids': ['https://openalex.org/I6141010']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057379395', 'display_name': 'Luís Costa', 'orcid': 'https://orcid.org/0000-0002-4782-7318'}, 'institutions': [{'id': 'https://openalex.org/I4210149283', 'display_name': 'Hospital de Santa Maria', 'ror': 'https://ror.org/05bz1tw26', 'country_code': 'PT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210149283']}], 'countries': ['PT'], 'is_corresponding': False, 'raw_author_name': 'Luis Costa', 'raw_affiliation_strings': ['8Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal;'], 'affiliations': [{'raw_affiliation_string': '8Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal;', 'institution_ids': ['https://openalex.org/I4210149283']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5107343489', 'display_name': 'Thomas Bachelot', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210105738', 'display_name': 'Centre Léon Bérard', 'ror': 'https://ror.org/01cmnjq37', 'country_code': 'FR', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210105738']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Thomas Bachelot', 'raw_affiliation_strings': ['9Medical Oncology, Centre Léon Bérard, France;'], 'affiliations': [{'raw_affiliation_string': '9Medical Oncology, Centre Léon Bérard, France;', 'institution_ids': ['https://openalex.org/I4210105738']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028638789', 'display_name': 'Ciara O’Brien', 'orcid': 'https://orcid.org/0000-0002-3769-1883'}, 'institutions': [{'id': 'https://openalex.org/I4210092852', 'display_name': 'Manchester University NHS Foundation Trust', 'ror': 'https://ror.org/00he80998', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210092852']}, {'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}, {'id': 'https://openalex.org/I4210133995', 'display_name': 'The Christie NHS Foundation Trust', 'ror': 'https://ror.org/03v9efr22', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210133995']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Ciara O’Brien', 'raw_affiliation_strings': ['10Christie Hospital NHS Foundation Trust, University of Manchester, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '10Christie Hospital NHS Foundation Trust, University of Manchester, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210092852', 'https://openalex.org/I28407311', 'https://openalex.org/I4210133995']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016843577', 'display_name': 'Gail S. Wright', 'orcid': 'https://orcid.org/0000-0002-3795-7573'}, 'institutions': [{'id': 'https://openalex.org/I4210118420', 'display_name': 'Florida Cancer Specialists & Research Institute', 'ror': 'https://ror.org/02px37122', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210118420']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gail Wright', 'raw_affiliation_strings': ['11Florida Cancer Specialists, New Port Richey, FL, United States;'], 'affiliations': [{'raw_affiliation_string': '11Florida Cancer Specialists, New Port Richey, FL, United States;', 'institution_ids': ['https://openalex.org/I4210118420']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029250198', 'display_name': 'Masashi Shimura', 'orcid': 'https://orcid.org/0000-0003-1233-4588'}, 'institutions': [{'id': 'https://openalex.org/I4210124059', 'display_name': 'Taiho Oncology (United States)', 'ror': 'https://ror.org/02z43nn16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210124059']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Masashi Shimura', 'raw_affiliation_strings': ['12Taiho Oncology, Inc., Princeton, NJ, United States;'], 'affiliations': [{'raw_affiliation_string': '12Taiho Oncology, Inc., Princeton, NJ, United States;', 'institution_ids': ['https://openalex.org/I4210124059']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058426048', 'display_name': 'Gareth Tomlinson', 'orcid': 'https://orcid.org/0009-0002-7731-8829'}, 'institutions': [{'id': 'https://openalex.org/I4210124059', 'display_name': 'Taiho Oncology (United States)', 'ror': 'https://ror.org/02z43nn16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210124059']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gareth Tomlinson', 'raw_affiliation_strings': ['12Taiho Oncology, Inc., Princeton, NJ, United States;'], 'affiliations': [{'raw_affiliation_string': '12Taiho Oncology, Inc., Princeton, NJ, United States;', 'institution_ids': ['https://openalex.org/I4210124059']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113839517', 'display_name': 'Maciej Gil', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210124059', 'display_name': 'Taiho Oncology (United States)', 'ror': 'https://ror.org/02z43nn16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210124059']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Maciej Gil', 'raw_affiliation_strings': ['12Taiho Oncology, Inc., Princeton, NJ, United States;'], 'affiliations': [{'raw_affiliation_string': '12Taiho Oncology, Inc., Princeton, NJ, United States;', 'institution_ids': ['https://openalex.org/I4210124059']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5060044961', 'display_name': 'Nicholas C. Turner', 'orcid': 'https://orcid.org/0000-0001-8937-0873'}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Nicholas Turner', 'raw_affiliation_strings': ['13Royal Marsden Hospital, Institute of Cancer Research, London, England, United Kingdom'], 'affiliations': [{'raw_affiliation_string': '13Royal Marsden Hospital, Institute of Cancer Research, London, England, United Kingdom', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}], 'institution_assertions': [], 'countries_distinct_count': 5, 'institutions_distinct_count': 17, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.573, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.999956, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 84, 'max': 93}, 'biblio': {'volume': '84', 'issue': '9_Supplement', 'first_page': 'RF01', 'last_page': '04'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12379', 'display_name': 'Cancer Diagnosis and Treatment', 'score': 0.9882, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12379', 'display_name': 'Cancer Diagnosis and Treatment', 'score': 0.9882, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12287', 'display_name': 'Fibroblast Growth Factor Research', 'score': 0.9871, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11287', 'display_name': 'Cancer Genomics and Diagnostics', 'score': 0.9777, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7364045}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.6284644}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.58431864}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.53756154}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.51631063}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.51011616}, {'id': 'https://openalex.org/C31760486', 'wikidata': 'https://www.wikidata.org/wiki/Q7180990', 'display_name': 'Phases of clinical research', 'level': 3, 'score': 0.44852582}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.158853}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs23-rf01-04', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.8, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3203106735', 'https://openalex.org/W3200352014', 'https://openalex.org/W2989121736', 'https://openalex.org/W2955569507', 'https://openalex.org/W2892677547', 'https://openalex.org/W2581171191', 'https://openalex.org/W2077649377', 'https://openalex.org/W2037317309', 'https://openalex.org/W2001196910', 'https://openalex.org/W1999702412'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Fibroblast': [2], 'growth': [3, 23], 'factor': [4, 24], 'receptor': [5, 25], '1': [6], '(FGFR1)': [7], 'gene': [8, 106, 164, 533], 'amplification': [9, 435, 534], 'and': [10, 30, 57, 87, 140, 150, 219, 253, 287, 308, 362, 394, 446, 517], 'overexpression': [11], 'is': [12, 31, 473], 'associated': [13], 'with': [14, 74, 78, 371, 428, 433, 441, 463, 524], 'an': [15, 130], 'adverse': [16, 349, 415], 'prognosis': [17], 'in': [18, 33, 72, 76, 167, 174, 202, 263, 300, 391, 426, 448, 455, 521], 'hormone': [19], 'receptor–positive': [20], '(HR+)/human': [21], 'epidermal': [22], '2–negative': [26], '(HER2−)': [27], 'breast': [28, 38, 80, 101, 431, 528], 'cancer': [29, 102, 159, 432, 529], 'observed': [32, 299], '~10%': [34], 'of': [35, 52, 62, 93, 134, 271, 278, 281, 337, 465, 519, 538], 'all': [36, 289], 'invasive': [37], 'cancers.': [39], 'The': [40, 234, 334, 458], 'phase': [41, 511], '2': [42, 401], 'FOENIX-MBC2': [43, 514], 'study': [44, 384, 409, 468], '(NCT04024436)': [45], 'was': [46, 181, 237, 298, 312, 339, 461], 'designed': [47], 'to': [48, 383, 408, 451], 'evaluate': [49], 'the': [50, 91, 238, 309, 352, 466, 510, 539], 'effect': [51], 'futibatinib,': [53], 'a': [54, 151, 206, 268, 276, 324, 372, 442], 'highly': [55], 'selective': [56], 'potent': [58], 'irreversible': [59], 'covalent': [60], 'inhibitor': [61, 156, 292], 'FGFR1–4': [63], '(FDA-approved': [64], 'for': [65, 90, 99, 120, 157], 'intrahepatic': [66], 'cholangiocarcinoma),': [67], 'used': [68], 'either': [69], 'alone': [70], 'or': [71, 136, 178, 188, 228, 379, 387], 'combination': [73], 'fulvestrant': [75, 98, 221, 422, 453], 'patients': [77, 94, 260, 303, 322, 345, 370, 403, 427, 523], 'metastatic': [79], 'cancer.': [81], 'Here,': [82], 'we': [83], 'report': [84], 'final': [85], 'efficacy': [86, 516], 'safety': [88, 459, 518], 'data': [89], 'cohort': [92], 'receiving': [95], 'futibatinib': [96, 214, 520], 'plus': [97, 421], 'HR+/HER2−': [100, 430, 527], 'harboring': [103, 530], 'high-level': [104, 531], 'FGFR1': [105, 163, 189, 197, 434, 532], 'amplification.': [107], 'Methods:': [108], 'Patients': [109, 211, 266], 'were': [110, 138, 200, 232, 261, 267, 367, 389, 400, 417], 'eligible': [111], 'if': [112], 'they': [113], 'had': [114, 123, 129, 141, 274, 288, 323, 346, 405], 'disease': [115, 125, 224], 'progression': [116], 'after': [117], 'prior': [118, 283, 438], 'therapy': [119], 'advanced/metastatic': [121, 526], 'disease,': [122], 'measurable': [124], 'per': [126, 194], 'RECIST': [127], 'v1.1,': [128], 'ECOG': [131], 'performance': [132], 'status': [133], '0': [135], '1,': [137], 'fulvestrant-naïve,': [139], 'previously': [142], 'received': [143, 212, 275, 290], '1–2': [144], 'endocrine-containing': [145], 'therapies,': [146], '≤1': [147], 'chemotherapy': [148], 'regimen,': [149], 'cyclin-dependent': [152], 'kinase': [153], '4/6': [154], '(CDK4/6)': [155], 'advanced': [158, 429], '(unless': [160], 'ineligible).': [161], 'High-level': [162], 'amplification,': [165], 'determined': [166], 'tumor': [168, 203], 'tissue': [169, 204], 'using': [170, 209], 'next-generation': [171], 'sequencing,': [172], 'fluorescence': [173], 'situ': [175], 'hybridization': [176], '(FISH),': [177], 'similar': [179], 'assays,': [180], 'defined': [182], 'as': [183], 'FGFR1/centromere': [184], '8': [185], 'ratio': [186], '≥5': [187], 'copy': [190], 'number': [191], '≥10': [192], 'signals': [193], 'cell.': [195], 'Local': [196], 'determination': [198], 'results': [199, 454, 508], 'confirmed': [201, 325], 'by': [205], 'central': [207], 'laboratory': [208], 'FISH.': [210], 'oral': [213], '20': [215], 'mg': [216], 'once': [217], 'daily': [218], 'standard': [220], 'dosing': [222], 'until': [223], 'progression,': [225], 'unacceptable': [226], 'toxicity,': [227], 'other': [229], 'discontinuation': [230], 'criteria': [231], 'met.': [233], 'primary': [235], 'endpoint': [236], '6-month': [239], 'progression-free': [240], 'survival': [241], '(PFS)': [242], 'rate.': [243], 'Key': [244], 'secondary': [245], 'endpoints': [246], 'included': [247], 'objective': [248], 'response': [249, 327, 338], 'rate': [250], '(ORR),': [251], 'PFS,': [252], 'overall': [254], 'safety.': [255], 'Results:': [256], 'Overall,': [257], '22': [258], 'female': [259], 'enrolled': [262], 'this': [264], 'cohort.': [265], 'median': [269, 277, 310, 335], 'age': [270], '58': [272], 'years,': [273], '3': [279, 374], 'lines': [280], 'any': [282], 'systemic': [284], 'anticancer': [285], 'therapy,': [286], 'CDK4/6': [291, 439], 'pretreatment.': [293], 'PFS': [294, 311, 449], 'at': [295], '6': [296], 'months': [297], '10': [301], '(45.5%)': [302], '(95%': [304, 314], 'CI:': [305, 331], '24.4,': [306], '67.8)': [307], '7.2': [313], 'confidence': [315], 'interval': [316], '[CI]:': [317], '2.1,': [318], '7.6)': [319], 'months.': [320, 343], 'Four': [321], 'partial': [326], '(ORR:': [328], '18.2%;': [329], '95%': [330], '5.2,': [332], '40.3).': [333], 'duration': [336], '6.3': [340], '(range:': [341], '3.3–12.8)': [342], 'All': [344], '≥1': [347], 'treatment-related': [348, 413], 'event': [350], '(TRAE),': [351], 'most': [353], 'common': [354], 'being': [355], 'hyperphosphatemia': [356], '(95.5%),': [357], 'alopecia': [358], '(54.5%),': [359], 'constipation': [360], '(45.5%),': [361], 'dry': [363], 'mouth': [364], '(40.9%).': [365], 'There': [366, 399], '5': [368], '(22.7%)': [369], 'Grade': [373, 377], 'TRAE': [375], '(no': [376], '4': [378], '5).': [380], 'TRAEs': [381, 406], 'leading': [382, 407], 'treatment': [385, 410], 'interruption': [386], 'reduction': [388], 'seen': [390], '9': [392], '(40.9%)': [393], '15': [395], '(68.2%)': [396], 'patients,': [397], 'respectively.': [398], '(9.1%)': [402], 'who': [404], 'discontinuation.': [411], 'No': [412], 'serious': [414], 'events': [416], 'reported.': [418], 'Conclusions:': [419], 'Futibatinib': [420], 'showed': [423], 'antitumor': [424], 'activity': [425], 'progressing': [436], 'on': [437], 'inhibitors,': [440], 'numerically': [443], 'higher': [444], 'ORR': [445], 'doubling': [447], 'relative': [450], 'historical': [452], 'post-CDK4/6': [456], 'patients.': [457], 'profile': [460], 'consistent': [462], 'those': [464], 'individual': [467], 'drugs.': [469], 'Further': [470], 'biomarker': [471], 'work': [472], 'ongoing.': [474], 'Citation': [475], 'Format:': [476], 'Senthil': [477], 'Damodaran,': [478], 'Fabrice': [479], 'André,': [480], 'Nisha': [481], 'Unni,': [482], 'Marta': [483], 'Ferreira,': [484], 'Karthik': [485], 'Giridhar,': [486], 'Brooke': [487], 'Daniel,': [488], 'Marco': [489], 'Colleoni,': [490], 'Luis': [491], 'Costa,': [492], 'Thomas': [493], 'Bachelot,': [494], 'Ciara': [495], 'O’Brien,': [496], 'Gail': [497], 'Wright,': [498], 'Masashi': [499], 'Shimura,': [500], 'Gareth': [501], 'Tomlinson,': [502], 'Maciej': [503], 'Gil,': [504], 'Nicholas': [505], 'Turner.': [506], 'Final': [507], 'from': [509], '2,': [512], 'open-label': [513], 'study:': [515], 'adult': [522], 'locally': [525], '[abstract].': [535], 'In:': [536], 'Proceedings': [537], '2023': [540, 546], 'San': [541, 549], 'Antonio': [542], 'Breast': [543], 'Cancer': [544, 555], 'Symposium;': [545], 'Dec': [547], '5-9;': [548], 'Antonio,': [550], 'TX.': [551], 'Philadelphia': [552], '(PA):': [553], 'AACR;': [554], 'Res': [556], '2024;84(9': [557], 'Suppl):Abstract': [558], 'nr': [559], 'RF01-04.': [560]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4396591836', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}], 'updated_date': '2024-12-11T21:37:40.399733', 'created_date': '2024-05-03'}